Evidence map›Paper›PMID 40611149›Full record

ArticleBMC biology2025

Accurate prediction of synergistic drug combination using a multi-source information fusion framework.

Shuting Jin, Huaze Long, Anqi Huang, Jianming Wang, Xuan Yu, Zhiwei Xu, Junlin Xu

Abstract read
In one paragraph

Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shuting JinSchool of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Huaze LongSchool of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Anqi HuangSchool of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Jianming WangDepartment of Integrative Biotechnology, Yonsei University, Incheon, 21983, Republic of Korea.
Xuan YuDepartment of Radiology, Henan Provincial People's Hospital and the People's Hospital of Zhengzhou University, Zhengzhou, 450000, Henan, China.
Zhiwei XuSchool of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Junlin XuSchool of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China. xjl@wust.edu.cn.

Funding

the Hubei Provincial Natural Science Foundation of China 2024AFB275the Hubei Provincial Natural Science Foundation of China 2024AFB307the National Natural Science Foundation of China No.62302156the National Natural Science Foundation of China No.62402351the Scientific Research Project of Education Department of Hubei Province Q20231109
6 · The paper itself

Abstract

backgroundAccurately predicting synergistic drug combinations is critical for complex disease therapy. However, the vast search space of potential drug combinations poses significant challenges for identification through biological experiments alone. Nowadays, deep learning is widely applied in this field. However, most methods overlook the important role of protein-protein interaction networks formed by gene expression products and the pharmacophore information of drugs in predicting drug synergy.

resultsWe propose MultiSyn, a multi-source information integration method for the accurate prediction of synergistic drug combinations. Specifically, we design a semi-supervised learning framework using an attributed graph neural network to integrate protein-protein interaction networks of gene expression products with multi-omics data, constructing initial cell line representations that incorporate multi-source information. Furthermore, we refine the initial cell line representation by adaptively integrating it with normalized gene expression profiles, enabling the extraction of cell line features that encapsulate global information. In addition, we decompose drugs into fragments containing pharmacophore information based on chemical reaction rules and construct a heterogeneous graph comprising atomic and fragment nodes. To enhance the capture of molecular structural information, we introduce a heterogeneous graph transformer to learn multi-view representations of heterogeneous molecular graphs. Extensive experiments show that MultiSyn outperforms several classical and state-of-the-art baselines in synergistic drug combination prediction tasks.

conclusionsThis study provides a powerful tool for inferring promising synergistic drug combinations. By leveraging attention mechanisms and pharmacophore information, MultiSyn identifies key substructures that are critical for synergy. Further visualization and case studies validate its effectiveness in capturing biologically meaningful features and identifying potential drug combinations.

Indexed as

Drug SynergismDrug CombinationsHumansNeural Networks, ComputerProtein Interaction MapsDrug CombinationsDrug combinationGraph neural networkMulti-source informationOmics data

Identifiers

PMID40611149
PMCPMC12226924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.